×

Therapy via targeted delivery of nanoscale particles using L6 antibodies

  • US 20040156846A1
  • Filed: 02/06/2003
  • Published: 08/12/2004
  • Est. Priority Date: 02/06/2003
  • Status: Abandoned Application
First Claim
Patent Images

1. A therapeutic method, comprising:

  • a) administering at least one bioprobe to at least a portion of a subject comprising a target; and

    b) administering energy from an energy source to the at least one bioprobe combined with the target; and

    wherein the bioprobe comprises a susceptor and a chimeric L6 antibody.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×